D
amage-associated molecular patterns (DAMPs), also known as endogenous danger signals, provide a major stimulus for helpful or harmful immune responses to sterile tissue insults, such as trauma or ischemia. [1] [2] [3] Typically, DAMPs contain hydrophobic regions within their structure 2 that, when exposed, act as alarm signals to the innate immune system by binding and activating pattern-recognition receptors. 2, 4, 5 In previous work, 6 we found that enrichment of human monocyte/macrophages with unesterified cholesterol (UC), a process that occurs within atherosclerotic plaques, 7, 8 provokes the release of highly procoagulant microvesicles ([MVs] , also called microparticles) through induction of apoptosis. For several reasons, we hypothesized that UC-induced MVs (UCMVs) could also serve as novel platforms for the transport of DAMPs. First, apoptotic MVs form by budding from the cell surface, 6, [9] [10] [11] [12] and so they possess a bilayer membrane structure with both hydrophobic and hydrophilic domains that appear uniquely suited to carry partially hydrophobic danger signals. 5 Second, MVs have been studied mostly in the context of their transport of tissue factor, a potent procoagulant molecule, 6, 10, 12 but surprisingly, only a minority of MVs carry detectable amounts of tissue factor. 6, 10, 13 This result led us to propose that the MVs in our experimental systems might mediate novel pathogenic effects that are independent from coagulation. 6, 10 Third, MVs produced under some, 12, [14] [15] [16] [17] but not all, 12, 15, 18 circumstances have been reported to activate endothelial monolayers in vitro. Our initial studies to assess the role of UCMVs in sterile inflammation showed that their injection into rats markedly increased leukocyte rolling and adherence to postcapillary venules, indicative of robust endothelial activation in vivo. 6, 19 Nevertheless, the molecular mechanisms for the production of MVs that activate endothelial cells and the basis for UCMV-endothelial interactions remain uncharacterized.
In the current study, we focused on the molecular and cellular processes responsible for the production of cholesterol-induced MVs capable of acute endothelial activation; the nature of the danger signals carried by these particles; the pattern-recognition receptors that mediate their recognition by endothelium; and endogenous pathways for detoxification of UCMV-associated DAMPs. Our results implicate UCMVs as novel carriers of DAMPs that may promote maladaptive immune responses in atherosclerosis. Moreover, we now report unexpected functions for 2 molecules previously shown to affect arterial plaque formation in vivo-namely, the lectin-like oxidized low-density lipoprotein receptor-1 (LOX1) receptor 20 and paraoxonase-1 (PON1).
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Materials and Methods
We prepared UCMVs by enrichment of human THP-1 monocytic cells with UC, in the absence of other manipulations, and then harvested their conditioned media and purified the MVs by sequential ultracentrifugation as previously described. 6 We assessed the ability of UCMVs to provoke a classic DAMP-induced, sterile inflammatory response-namely, the recruitment of leukocytes or monocytes to microvascular endothelium in vivo-to aortic explants from wild-type and mutant mice ex vivo and to cultured monolayers of human microvascular endothelial cells (hMVECs) in vitro. To study THP-1 cells during UC enrichment and generation of biologically active UCMVs, we used flow cytometry, confocal fluorescent microscopy, and chemical assay of key mediators. To investigate endogenous pathways for detoxification of UCMV-associated DAMPs, high-density lipoprotein (HDL) was isolated from human plasma and recombinant evolved human PON1 was obtained from Dr Dan S. Tawfik (Weizmann Institute of Science, Rehovot, Israel). Additional experiment details are provided in the online-only Data Supplement.
Results
UCMVs Robustly Enhance Leukocyte Recruitment to Microvascular Endothelium In Vivo, to Aortic Endothelium Ex Vivo, and to Cultured Human Endothelial Monolayers In Vitro
Consistent with our initial preliminary reports, 6, 19 we found that injection of UCMVs into the tail vein of rats markedly increased leukocyte rolling ( Figure 1A and 1C) and adherence ( Figure 1B ) in vivo to postcapillary mesenteric venules, as assessed by intravital microscopy. The effect was so strong that we also observed leukocyte rolling to precapillary arterioles when they were in the field of view (not shown), despite the higher hemodynamic forces seen by the endothelium of those vessels. To examine direct effects of UCMVs on endothelium, we tested the responses elicited by these particles when added to thoracic aortic explants from wild-type C57BL/6J mice ex vivo ( Next, we examined candidate molecules that could mediate the recruitment of monocytes to endothelial cells exposed to UCMVs. A 5-hour exposure of cultured hMVECs to UCMVs specifically increased cellular levels of intercellular adhesion molecule-1 (ICAM1), without affecting vascular cell adhesion molecule-1 or E-selectin in this system ( Figure IIA in the online-only Data Supplement). Activation of a fourth major cell adhesion molecule, P-selectin, involves translocation from intracellular stores to the cell surface, not regulated expression. 23 To test functional roles for ICAM1 and P-selectin in UCMV-induced monocyte adherence to endothelium, we found that anti-ICAM1 blocking antibodies, but not nonimmune isotype controls, essentially blocked the ability of UCMVs to induce monocyte adherence to thoracic aortic explants from wild-type mice ( Figure IIB in the onlineonly Data Supplement). However, anti-P-selectin blocking antibodies did not inhibit the ability of UCMVs to induce monocyte adherence to mouse thoracic aortic explants ( Figure  IIB in the online-only Data Supplement). These results, along with our earlier work, 6 indicate that UCMVs provide a damage-associated signal that provokes endothelial recruitment of leukocytes 12 through the display of functional ICAM1. Because endogenous danger signals can originate from mitochondria, 3, 24, 25 we examined the effect of UC enrichment alone, without scavenger receptor engagement or esterification inhibitors, 26 on mitochondrial integrity in human THP-1 monocytes, the cells of origin for UCMVs. We found that enrichment of these cells with UC, in the absence of other manipulations, induced severe mitochondrial dysfunction, as Figure 2C ). In addition, by 20 hours, UC enrichment more than doubled the cellular content of lipid peroxides, assessed by the thiobarbituric acid reactive substances assay ( Figure 2D ). Next, we used chemical inhibitors to determine whether damaged mitochondria are the source of these new superoxide and peroxide molecules. Mitochondrial complexes I and III are commonly thought to be sites for superoxide anion generation 27 because of premature electron leakage to oxygen, but some experimental evidence suggests that complex II may also serve as a source of mitochondrial superoxide during exposure of cells to artificially peroxidized low-density lipoprotein. 28 We found that pretreatment with 2-thenoyltrifluoroacetone, a mitochondrial complex II inhibitor, essentially blocked UC-induced accumulation of superoxide and H 2 O 2 in human THP-1 cells, detected by mitoSOX and by 2΄,7΄-dichlorofluorescein ( Figure 2E and 2F). Inhibitors of the other mitochondrial complexes (rotenone for complex I, myxothiazol for complex III, NaCN for complex IV, and the mitochondria uncoupler carbonyl cyanide m-chlorophenylhydrazone) and inhibitors of NAD(P)H oxidases (apocynin and diphenyleneiodonium) each failed to affect UC-induced accumulation of peroxide or H 2 O 2 (not shown). Thus, mitochondria, and specifically complex II, are the major source of intracellular superoxide and peroxides generated during UC enrichment of human THP-1 cells.
Enrichment of Human
UCMVs Carry Malondialdehyde-Like Peroxidized Epitopes on Their Surface
We next sought to determine whether peroxidized molecules are present on UCMVs, and if so, whether these molecules might be biologically active. UC enrichment of human THP-1 monocytes for 20 hours caused the production of UCMVs with abundant surface epitopes recognized by the EO14 monoclonal antibody (dots within the orange ovals, Figure 3A -3C). This antibody is known primarily for its binding to low-density lipoprotein that has been modified by malondialdehyde (MDA), 29 a reactive compound generated during autoxidation of polyunsaturated fatty acids. 30 More recent studies indicate that EO14 also recognizes MDA-like peroxidized epitopes on apoptotic cells. 29 Consistent with our previous report that UC enrichment induces apoptosis of human monocyte/macrophages 6 and our current finding of thiobarbituric acid reactive substances in UC-enriched cells ( Figure 2D ), we now found that the EO14 antibody also recognizes the surface of UC-enriched, but not control, THP-1 cells (dots within the green ovals in Figure 3A -3C and green fluorescent regions in Figure 3D and 3G).
Surface-exposed phosphatidylserine is characteristic of both MVs and apoptotic cells. 6 Exteriorization of phosphatidylserine from the inner to the outer leaflet of the plasma membrane during apoptosis may be facilitated by its peroxidation by specific reactive molecules that originate from dysfunctional mitochondria. 31 To determine whether there is a relationship between UC-induced MDA-like epitopes and cell-surface exposure of phosphatidylserine, we performed colocalization studies. By confocal fluorescence microscopy, both EO14 (green fluorescence in Figure 3G and 3I) and annexin V (a marker of exteriorized phosphatidylserine, indicated by red fluorescence in Figure 3H and 3I) bound to the surface of UC-enriched THP-1 monocytes but not detectably to control cells ( Figure 3D-3F) . Importantly, EO14 and annexin V colocalized on the surface of UC-treated THP-1 cells, concentrated in small, circumscribed domains (arrows in Figure 3G -3I). These domains exhibit approximately the same size as UCMVs (≈1 µm) and resemble published images of microvesicle release. 15 These results indicate that UC enrichment of the human THP-1 monocytes induces the generation of molecules that are detected by the thiobarbituric acid reactive substances assay and recognized on the cell surface by the EO14 antibody. Moreover, these molecules appear to be directly released on MVs.
MDA-Like Peroxidized Molecules Formed Through Mitochondrial Dysfunction Are a Major Class of UCMV-Associated Danger Signals Required to Activate Endothelium
To determine whether peroxidized molecules on UCMVs contribute to the ability of these particles to activate endothelium to recruit leukocytes/monocytes, we isolated UCMVs and then treated them for 1 hour with 0 (control) or 70 µmol/L NaBH 4 , a chemical reducing agent. The UCMVs were then washed and reisolated by ultracentrifugation. Flow cytometry of the UCMVs indicated that NaBH 4 treatment produced a substantial loss of MDA-like epitopes recognized by the EO14 antibody ( Figure  4A ). More importantly, we found that the NaBH 4 treatment significantly attenuated UCMV-induced recruitment of monocytes to mouse thoracic aorta explants ex vivo ( Figure 4B ) and essentially attenuated UCMV-induced monocyte recruitment to cultured hMVECs ( Figure III in the online-only Data Supplement).
To determine whether these biologically active, MDA-like molecules carried by UCMVs originate from cholesterolinduced mitochondrial dysfunction, we pretreated human THP-1 monocytes with a complex II inhibitor (10 µmol/L 2-thenoyltrifluoroacetone) for 1 hour before UC enrichment. Complex II inhibition blocked cholesterol-induced cellsurface display of MDA-like peroxidized epitopes, as Figure 2E and  2F) . Surprisingly, 2-thenoyltrifluoroacetone pretreatment did not protect THP-1 monocytes at all from UC-induced apoptosis ( Figure IVB in the online-only Data Supplement). Consistent with its effects on cell-surface display of EO14-positive epitopes, complex II inhibition markedly attenuated the appearance of MDA-like molecules on the UCMVs produced by these cells ( Figure 4C ). Moreover, complex II inhibition during UCMV generation blocked the ability of these particles to induce monocyte adherence to mouse thoracic aorta explants ( Figure  4D ). Thus, the danger signals carried by UCMVs originate from mitochondrial dysfunction, specifically requiring complex II.
The LOX1 Mediates Endothelial Recognition of Danger Signals on UCMVs
Recent studies have demonstrated that the LOX1 (HGMWapproved symbol OLR1), a scavenger receptor expressed on endothelium, 20 ,32 strongly affects atherogenesis in murine models in vivo. 20, 32 Moreover, human LOX1 gene variants have been linked to myocardial infarction. 33 Because LOX1 is also involved in innate immunity, 34, 35 including recognition of at least 2 DAMPs, heat shock protein-60 and -70, 35 we explored whether this receptor might also recognize danger signals on UCMVs. We found that treatment of cultured hMVECs with UCMVs induced endothelial LOX1 expression, assessed by immunoblots ( Figure 5A ). We then used 2 approaches to test a functional role for LOX1: antibody inhibition and use of aortic explants from Lox1 knockout mice ( Figure 5B-5C ). Inhibitory anti-LOX1 monoclonal antibodies, but not an IgG2b isotype control, significantly inhibited the ability of UCMVs to induce monocyte adherence to cultured hMVECs ( Figure 5B ). Most importantly, we found that aortic explants from Lox1 knockout mice were essentially unable to respond to UCMVs, whereas simultaneously treated explants from wild-type mice responded robustly by increasing monocyte recruitment ( Figure 5C ). These findings indicate that LOX1 is required for UCMV-induced endothelial activation. Moreover, microvesicle-associated danger signals may be the key endogenous ligands for LOX1.
Earlier work by us 36 and others 32 indicated that LOX1 can induce endothelial expression of cell adhesion molecules via activation of nuclear factor-κB. 32, 36 Here, we found that inhibition of nuclear factor-κB signaling in hMVECs by the nuclear factor-κB inhibitor MG-132 significantly attenuated UCMVinduced ICAM1 expression ( Figure VA in the online-only Data Supplement). The effects were even more striking when we exposed hMVECs to the UCMVs that we had generated from primary human peripheral blood mononuclear cells. Addition 
HDL and Its Associated Enzyme PON1 Detoxify Danger Signals on UCMVs
Mechanisms to limit maladaptive responses to DAMPs released during sterile tissue damage have been documented in several circumstances, 4, 37 although not in the context of atherosclerosis or cholesterol enrichment. 25 Studies in animal models have shown direct antiatherogenic roles for HDL 38 and the HDL-associated enzyme PON1 in vivo. 21, 22 Moreover, HDL has been reported to suppress certain immune reactions, 39 but its effects on DAMPs have not been previously described. Here, we determined whether HDL or PON1 can act on UCMVs and their associated danger signals. We first treated isolated UCMVs with a subphysiological concentration of HDL, equivalent to 4 mg HDL cholesterol per dL, followed by reisolation. This treatment substantially lowered the content of MDA-like epitopes on UCMVs, as assessed by EO14 antibody binding ( Figure 6A ) and significantly blunted the ability of the treated UCMVs to induce monocyte adherence to the aortic endothelium ( Figure 6B ) or to the cultured hMVECs ( Figure VI in the online-only Data Supplement). Although paraoxonases were named for their ability to act on a man-made insecticide from the 1940s, 21 endogenous natural substrates have not been definitively identified. Here, we isolated UCMVs and then incubated them for 1 hour at 37°C without or with 100 µg of recombinant human PON1 per mL, a concentration that falls within the range of PON1 levels we previously found in human plasma. 22 These UCMVs were then reisolated by ultracentrifugation and analyzed. We found that the enzyme decreased MDA-like epitopes on UCMVs ( Figure 6C ) and significantly attenuated the ability of these particles to activate the endothelium of mouse thoracic aorta explants, as assessed by the subsequent adherence of monocytes ( Figure 6D ). Thus, detoxification of endogenous danger signals on persistent apoptotic MVs may be a normal function of HDL and PON1. Moreover, our results suggest that DAMPs on UCMVs and other apoptotic membranes might be natural substrates for PON1.
Discussion
In the current study, we found that upon cholesterol enrichment, human monocytic cells release MVs that contain biologically active danger signals. Cholesterol enrichment occurs in vivo when monocyte/macrophages ingest retained and aggregated lipoproteins in the vessel wall, 8, 38 damaged or senescent cells, and related debris. Our results suggest that the release of UCMVs may function to recruit additional phagocytes when the local cholesterol load becomes too great. Because macrophages cannot catabolize the steroid nucleus, they must use other processes to accommodate exogenous UC. These processes include transport of UC into mitochondria for processing by CYP27A1, also known as sterol 27-hydroxylase. 40 In our experimental system, similar to atherosclerotic plaques in vivo, 41, 42 the pathways to accommodate UC become overwhelmed, leading to mitochondrial dysfunction ( Figure  2 ), apoptosis, 6 and the release of MVs with biologically active danger signals that activate endothelium (Figures 1, 3 , and 4).
12 Consistent with this model, our previous work showed that removal of UC in vivo from the tissues of genetically hypercholesterolemic animals can normalize leukocyte adherence to microvascular endothelium. 43 Endothelial activation by UCMVs was manifested by increased cellular levels of LOX1 and ICAM1 and robust adherence of monocytes (see Results). The effect of UCMVs on endothelial ICAM1 was highly specific ( Figure IIA and IIB in the online-only Data Supplement), thereby, accurately modeling the effects of MVs isolated from human atherosclerotic plaques. 17 In our study, the mechanism by which UCMVs increased endothelial ICAM1 required engagement 4 UCMVs per µL, followed by rinsing and then detergent extraction. Displayed are immunoblots for LOX1 and, as a loading control, GAPDH. B, Human endothelial monolayers were preincubated for 1 hour in unsupplemented medium (2 leftmost columns) or in a medium supplemented with a monoclonal blocking antibody against LOX1 (anti-LOX1 mAb) or a nonimmune isotype control antibody (IgG2b Isotype). Additional medium without (Control) or with UCMVs was then added, followed by 5 more hours of incubation and then rinsing. Endothelial activation was assessed by the subsequent adherence of fluorescent-labeled monocytes. C, Thoracic aortic explants from wild-type or Lox1 knockout mice (Lox1 KO) were incubated ex vivo for 5 hours at 37°C without or with UCMVs, as indicated, followed by rinsing and then the adherence of fluorescently labeled monocytes was assessed. B and C, Counts of adherent, fluorescent monocytes per high-power field ([HPF]; mean±SEM, n=3-5). In these panels, P<0.001 by ANOVA, displayed are significance levels for individual pairwise comparisons by the Student-Newman-Keuls test. Figure 5B and 5C) and active nuclear factor-κB, a known inducer of ICAM1 gene transcription 32 ( Figure VA and VB in the online-only Data Supplement). These results are in line with our previous report, in which we showed that other ligands for LOX1 induce endothelial expression of ICAM1. 44 An additional possibility was suggested by a recent report that plaque MVs can donate ICAM1 protein to endothelial cells. The ICAM1 content of plaque MVs in that study was low, 17 and putative transfer of ICAM1 from UCMVs to endothelial cells in our experimental systems should presumably remain unaffected by inhibition of nuclear factor-κB, an intracellular factor. Thus, our data support a model in which the dominant mechanism for UCMV-induced expression of ICAM1 by endothelial cells occurs via LOX1 engagement and nuclear factor-κB activation.
Mechanisms for noninflammatory removal of apoptotic bodies have been extensively studied, 45 as have the consequences of persistent apoptotic bodies and blebs, 12, 45, 46 but less information is available regarding the safe disposal of biologically active MVs. Here, we found a novel role for HDL and its associated enzyme, PON1, in the detoxification of danger signals on UCMVs. In healthy human adults, over 1 million cells die per second, 37 requiring mechanisms for the disposal and detoxification of potentially immunostimulatory material, which we now presume to include MVs and their associated DAMPs. In related work, Perkmann et al 47 preliminarily reported that a portion of circulating MVs from healthy human subjects display oxidized epitopes, which emphasizes the potential importance of our current finding that HDL and PON1 can neutralize such particles. Consistent with this premise, genetic deficiency of HDL 48 and human variants of PON1 49 have been linked to certain forms of autoimmunity. In the context of atherosclerosis, human coronary plaques have been shown to contain oxidation-specific epitopes on macrophages, including foam cells. 50, 51 Such cell-associated material would be a likely source of biologically active plaque MVs that should also be targets for HDL and PON1.
As additional triggers for sterile inflammation become identified, the concept of endogenous danger signals continues to broaden. The first few DAMPs to be recognized were intracellular molecules, such as heat shock proteins and highmobility group box 1 protein, that were released from damaged cells. 2, 4, 45 Damaged cells may also release mitochondria, which can activate innate immunity through persistent generation of ATP, a known DAMP, 3, 45 as well as through their misidentification as foreign by the innate immune system, because of the organelle's similarities with its bacterial ancestors. 24 In all of these circumstances, DAMPs originate from intracellular components that are inadvertently disgorged as a consequence of cellular damage in an apparently passive, unregulated fashion.
Danger signals on MVs differ from these canonical DAMPs in at least 3 ways. First, the generation of MVs requires active Figure 6 . High-density lipoprotein (HDL) and its associated enzyme paraoxonase-1 (PON1) detoxify danger signals on UCMVs. A and B, Unesterified cholesterol-induced microvescicles (UCMVs) were isolated from culture supernatants of human THP-1 monocytes and then incubated for 1 hour at 37°C without or with a subphysiological concentration of human HDL (100 μg HDL protein/mL, equivalent to 4 mg HDL cholesterol per 100 mL). Microvesicles were repurified from vehicle or HDL before our analyses. A, Representative histograms from flow cytometry of UCMVs stained with an IgMk isotype control antibody (blue curves), UCMVs stained with the EO14 antibody (filled purple curves), and HDL-treated UCMVs stained with the EO14 antibody (green curves). B, Wild-type murine aortic explants were incubated for 5 hours ex vivo with 0 (Control) or 3×10 4 per μL of UCMVs or HDL-treated UCMVs. Explants were rinsed and then endothelial activation was assessed by the adherence of labeled monocytes. C and D, UCMVs were isolated from culture supernatants of human THP-1 monocytes and then incubated for 1 hour at 37°C without or with recombinant evolved PON1 (100 μg/mL). Microvesicles were repurified from vehicle or PON1 before our analyses. C, Representative histograms from flow cytometry of UCMVs stained with an IgMk isotype control antibody (blue curves), UCMVs stained with the EO14 antibody (filled purple curves), and PON1-treated UCMVs stained with the EO14 antibody (green curves). D, Wild-type murine aortic explants were incubated for 5 hours ex vivo with 0 (Control) or 3×10 4 per µL of UCMVs or PON1-treated UCMVs. Explants were rinsed and then endothelial activation was assessed by the adherence of labeled monocytes. B and D, Mean±SEM, n=3-4. In each of these panels, P<0.001 by ANOVA, displayed are significance levels for individual pairwise comparisons by the Student-Newman-Keuls test. cellular processes, including plasma membrane blebbing via actomyosin-based abscission. 9, 11, 52 Second, the process of plasma membrane blebbing preserves the boundary between intracellular and extracellular compartments and, thereby, avoids indiscriminant release of intracellular contents. Thus, danger signals have to be transported or created on the external surface. Some MVs do not seem to contain danger signals, 12, 15, 18 suggesting selectivity in these processes. Third, our characterization of the biologically active ligands for LOX1, HDL, and PON1 implicates MDA-like moieties that are susceptible to chemical reduction. In contrast, several previously described DAMPs, such as high-mobility group box 1 protein, persist in reducing environments and become inactivated by oxidation. 4 Thus, these different DAMPs may be suited for different circumstances.
Overall, our study has implicated UCMVs as platforms for the transport of danger signals, LOX1 as a key patternrecognition receptor that recognizes these signals, and HDL and PON1 as detoxifiers. Danger signals on MVs may participate in healthy inflammation. Nevertheless, by promoting maladaptive immunologic and thrombotic responses, MVs from cholesterol-loaded human cells may be novel contributors to atherothrombosis and other disorders in vivo.
